Liu Jun, Liu Feila, Liang Tingting, Zhou Yue, Su Xiaohan, Li Xue, Zeng Jiao, Qu Peng, Wang Yali, Chen Fuli, Lei Qian, Li Gang, Cheng Panke
School of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing, China.
Department of Breast and Thyroid Surgery, Biological Targeting Laboratory of Breast Cancer, Academician (expert) workstation, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.
Cell Death Discov. 2024 Jun 15;10(1):287. doi: 10.1038/s41420-024-02064-6.
Myocardial infarction, commonly known as a heart attack, is a serious condition caused by the abrupt stoppage of blood flow to a part of the heart, leading to tissue damage. A significant aspect of this condition is reperfusion injury, which occurs when blood flow is restored but exacerbates the damage. This review first addresses the role of the innate immune system, including neutrophils and macrophages, in the cascade of events leading to myocardial infarction and reperfusion injury. It then shifts focus to the critical involvement of CD4+ T helper cells in these processes. These cells, pivotal in regulating the immune response and tissue recovery, include various subpopulations such as Th1, Th2, Th9, Th17, and Th22, each playing a unique role in the pathophysiology of myocardial infarction and reperfusion injury. These subpopulations contribute to the injury process through diverse mechanisms, with cytokines such as IFN-γ and IL-4 influencing the balance between tissue repair and injury exacerbation. Understanding the interplay between the innate immune system and CD4+ T helper cells, along with their cytokines, is crucial for developing targeted therapies to mitigate myocardial infarction and reperfusion injury, ultimately improving outcomes for cardiac patients.
心肌梗死,通常称为心脏病发作,是一种由心脏某部分血液供应突然中断导致组织损伤的严重病症。这种病症的一个重要方面是再灌注损伤,即血流恢复时损伤反而加剧。本综述首先探讨固有免疫系统,包括中性粒细胞和巨噬细胞,在导致心肌梗死和再灌注损伤的一系列事件中的作用。然后将重点转向CD4 +辅助性T细胞在这些过程中的关键参与。这些细胞在调节免疫反应和组织恢复中起关键作用,包括Th1、Th2、Th9、Th17和Th22等各种亚群,它们在心肌梗死和再灌注损伤的病理生理学中各自发挥独特作用。这些亚群通过多种机制促成损伤过程,诸如IFN-γ和IL-4等细胞因子影响组织修复与损伤加剧之间的平衡。了解固有免疫系统与CD4 +辅助性T细胞及其细胞因子之间的相互作用,对于开发减轻心肌梗死和再灌注损伤的靶向治疗方法至关重要,最终可改善心脏病患者的预后。